Purpose: To identify the barriers to antiepileptic drug (AED) adherence among adults with epilepsy (AWE). The impact of AED non-adherence on quality of life (QoL) was also examined. Method: Systematic design (SR) study. A search strategy was undertaken with no time limits, for articles published in English, in MEDLINE, CINANL, PsycINFO, EMBASE, Cochrane databases and grey literature sources. Eligibility criteria included participants with epilepsy over 18 years, who were prescribed AEDs. Adherence had to be defined and adherence assessment measurements identified. A screening process was undertaken to select eligible studies. Eight studies met the inclusion criteria and were included in a quantitative synthesis. Quality of evidence was conducted using the EBL critical appraisal checklist and assessing risk of bias within individual studies. Results: Across the included studies a high prevalence of non-adherence was identified. AED nonadherence was associated with specific beliefs about medications, being depressed or anxious, poor medication self-administration management, uncontrolled recent seizures, frequent medication dosage times, poor physician-patient relationship and perceived social support. Additionally, AED nonadherence impacted negatively on QoL as a result of poor seizure control. Conclusion: Although included studies were of good quality, risk of biases reduced the generalisability of results. Findings suggested that comprehensive adherence assessments should routinely be performed. Recommendations for future research include the use of longitudinal research designs and a follow up SR to include the 16-18-year-old population.
Introduction
Approximately 50 million people globally have epilepsy making it the most common neurological disease [1] . AEDs are considered the mainstay of treatment [2] and can result in 70% of patients achieving seizure freedom once an effective regime is followed [3] . "Medication adherence" is the extent to which individuals take their medications as prescribed with respect to dosage and dosage intervals [4] . The term "adherence" reflects contemporary patientcentered healthcare systems in which patients and prescribers collaborate on treatment plans, rather than patients simply "complying" with instructions [5] .
From the current literature, AED non-adherences rates among adults with epilepsy (AWE), range from 29 to 39% [6] . Therefore, the effectiveness of AED regimes is compromised leading to higher incidences of fractures, injuries and automobile accidents [7] . Retrospective research has demonstrated the impact of nonadherence on healthcare utilisation and costs as a result of increased emergency department attendances and inpatient admissions [6, 8] .
Consequently, AED non-adherence is associated with adverse clinical outcomes and increased mortality rates [7] . Patients may be being incorrectly classified as having refractory epilepsy [9] . Additionally, non-adherent AWE are known to have increased risks of convulsive status epilepticus [10] . However, the most serious consequence of AED non-adherence is the increased risk of sudden unexplained death in epilepsy patients [11] . Therefore, identifying the barriers to AED adherence is viewed as imperative to enabling practitioners develop appropriate strategies to improve adherence rates [6] .
It was evident that undertaking this SR was timely, as there has been a surge in researchers, investigating the reasons for AED non-adherence, with robust studies been published globally. While individual studies have identified specific barriers to AED adherence, contradictory findings emerged.
Well controlled epilepsy has been identified as leading to nonadherence [12] which contradicted other research which associated experiencing fewer seizures with more adherent behaviour [13] . Some argue it's the fear of and the occurrence of medication side-effects such as cognitive difficulty or weight gain that leads to reduced AED adherence [14] . However, others found adherence was dependent on treatment effectiveness rather than occurrence of side-effects [15] . It is also suggested that monotherapy increases adherence rates [13] . In contrast, adherence rates have been reported to be higher among AWE on polytherapy due to stronger medication necessity beliefs [16] .
Variances between research findings on this subject have been attributed to population, geographical and methodological differences between studies [17] . Furthermore, while most definitions presume adherence is a stable patient characteristic, evidence suggests it's a much more dynamic process [18] . Each of these factors have led to a lack of clarity on this subject and hindered the development of substantive conclusions.
The primary outcome measure of this SR was to determine AED adherence and non-adherence rates among AWE and thereupon identify the specific barriers that contribute to AEDnon-adherence. The secondary outcome measures were the impact on quality of life (QoL) for AWE that was attributed to AED non-adherence.
Methods

Search strategy and study selection
A systematic search for original research published in peerreviewed journals in the MEDLINE, CINANL, PsycINFO, EMBASE, and Cochrane databases without time limits was conducted. Eligibility criteria included: AWE over 18 years who were prescribed AEDs with a main focus being the identification of either inhibitors or enablers to AED adherence in AWE. Adherence had to be defined with the measurement used identified. Studies that used participants with learning disabilities, memory impairment or any severe co-morbidities were excluded to avoid introducing confounding factors. Only English language publications were considered due to lack of translation resources.
Search words/terms utilized both MeSH and non-MeSH: such as epilepsy or epilep* or anticonvulsant* or antiepilep* medication* or antiepilep* drug* or anti-epilep* medication* or anti-epilep* drug* (non-MeSH) OR Medication Adherence (MeSH) OR adher* (non-MeSH) OR compliance or comply or complies or compliant (non-MeSH) OR Compliance (MeSH) OR concord*(non-MeSH) OR barrier* or inhibit* or enable* or influenc* or influential or obstacle* or hinder* hindrance (non-MeSH). Variances existed across the databases regarding how MeSH terms and language and age limits could be applied.
Within grey literature the Open grey, Lenus, and Rian databases were searched. Additionally, "Epilepsia" "Seizure" and "Epilepsy & Behavior" journals were hand searched during dates not held within the MEDLINE database. Two review authors (GOR & JJOB) independently assessed titles and, where available, abstracts of the studies were identified by the search strategy against the eligibility criteria for inclusion in the review. In total, 1916 records were screened. A flow chart summary of the literature search is outlined in Fig. 1 . Eight records met the inclusion criteria [19] [20] [21] [22] [23] [24] [25] [26] . A list of excluded articles can be found as Supplementary material (S1).
Quality of evidence assessment and data collection
Critical appraisal of the evidence from each included study was undertaken using the EBL critical appraisal checklist [27] . Overall validity of a study required (Yes/Total) is !75% or ((No + Unclear)/ Total) is 25%. The results are outlined in Table 1 .
Apart from two studies [24, 25] , six studies had robust sample sizes. The use of participants with private health insurance [20] refractory epilepsy [21] computer literacy skills [23] poor seizure control and "underserved" healthcare access [25] very good seizure control [19, 26] limited findings generalisability. The introduction of confounding factors was reduced in six studies [19] [20] [21] [22] 25, 26] with stringent eligibility criteria. However, two studies [23, 24] did not outline any exclusion criteria for the AWE samples. In Hovinga et al. [23] the epilepsy diagnosis was selfreported, reducing internal validity. Three studies [22, 23, 25] failed to outline their sequence generation process, making judgement unclear. Only one study [20] used random selection processes.
Only five studies, reported their response rates with varying results: 55% [19, 26] , 22.1% [20] , 28% [23] , and 72% [24] . Two studies provided research incentives to participants [20, 23] which may lead to demographic bias [28] . The use of postal surveys in four studies [19, 20, 24, 26] may have increased response bias due to the non-participation of individuals with literacy difficulties [17] . One study [23] provided insufficient information to allow replication. This study did not disclose the questions posed to their physician sample [23] .
Three studies reported receiving both ethical approval and obtaining informed consent [20, 21, 25] . While four studies [19, 22, 24, 26] obtained ethical approval, no reference was made to consenting. Only one study [23] reported upholding anonymity. Two studies failed to report on any ethical aspects of their work [23, 25] hindering judgement.
Chapman et al. [19] was judged at high risk of attrition bias as scores were prorated where fewer than half of item scores were missing from the beliefs about medicines questionnaire [29] and perceived sensitivity to medicines scale [30] responses along with missing data in clinical and demographical information within individual items. In Ettinger et al. study [20] , 465 patients were included in the final analysed sample, yet only results from 463 participants were reported on. A data extraction table which can be found in Supplementary material (S2) was designed to extract data. Uniformity was upheld in reporting data. It was not possible to combine results in a metaanalysis due to heterogeneity across the included studies [19] [20] [21] [22] [23] [24] [25] [26] in relation to adherence measurements tools used and the actual adherence barriers investigated. Instead, the studies were analysed in terms of outcomes reported and a narrative synthesis was performed.
Results
Eight articles were included in study for review and are summarised in Table 2 .
Adherence assessments
Various adherence assessment tools were used across the included studies [19] [20] [21] [22] [23] [24] [25] [26] . Four studies [21, 22, 24, 25] used the Morisky Medication Adherence Scale (MMAS) [33] . Two studies [21, 24] used the MMAS-4 tool [33] and two studies [22, 25] used the MMAS-8 which was adapted into Chinese [33] for participants in Guo et al. study [22] . Hovinga et al. [23] used one-month recall period method [35] to measure adherence.
Two studies [19, 26] used a mixed methods approach using two items from the ESMS along with the MPR tool. MPR scores were calculated using the participants' medication records in both these studies [19, 26] . MPR is calculated by dividing the number of days on which medication was available by the number of days between the earliest prescription claims in the observation period through the end of the observation period with a threshold of <0.80 defining non-adherence [32] . Neither of these two studies [19, 26] outlined the time period used within the medication records to calculate MPR scores. In both studies [19, 26] , if it was not possible to calculate MPR, adherence was determined from ESMS scores alone. Ettinger et al. [20] used MPR alone to determine adherence rates by utilizing medical and pharmacy administrative claims data over a 6-month period.
Definitions of adherence and non-adherence
Varying definitions of adherence and non-adherence were recorded across all the included studies [19] [20] [21] [22] [23] [24] [25] [26] , depending on the instrument used to measure adherence. Chapman et al. [19] assessed adherence on two items related to medication taking within the ESMS [31] . Scores were summed in a range from 0 to 10 with higher scores indicating greater adherence. If it was not possible to calculate MPR data from medication records, adherence was then classified on the basis of their self-reported adherence scores alone. Ettinger et al. [20] determination of adherence from the MPR [32] meant higher numbers indicated better adherence, and a threshold of less than 80 was used to define non-adherence. In Ferrari et al. [21] adherence was classified as high if all four questions on the MMAS-4 [33] were answered as "no", moderate if one or two questions were answered as "yes", and low if more than two questions were answered as "yes". In this study, participants with moderate or low adherence were considered non-adherent.
Guo et al. [22] use of the Chinese version of the MMAS-8 [34] meant that items 1-7 are yes/no questions, in which a "no" answer receives a score of 1 and a "yes" answer receives a score of 0, except for item 5, which is reverse-scored. Item 8 was measured on a fivepoint scale with the responses "never", "once in a while", "sometimes", "usually", and "all the time" scored as 1, 0.75, 0.50, 0.25, and 0, respectively. The total score ranged from 0 to 8. Scores of 8, 6-7, and <6 indicated high, moderate, and low adherence in this study [22] . Hovinga et al. [23] use of the one month recall tool defined non-adherence as missing or stopping an AED dose in the last month.
In Jones et al. [24] participants were considered non-adherent if they scored a 1 or more on the MMAS-4 [33] . In Shallcross et al.
[25], a summed score was calculated on the MMAS-8 [36] with higher scores reflecting greater adherence (maximum adherence = 8). This study [25] did not outline the actual score which indicated adherence. Smithson et al. [26] definition of adherence was dependent on scores from the 2 items surveyed within the ESMS and MPR being calculated at >0.8. This study [26] did not indicate the scores necessary to be deemed adherent on the ESMS.
Adherence rates
Fig. 2 outlines AED adherence rates for seven studies [19, [21] [22] [23] [24] [25] [26] . In Ettinger et al. [20] , only the mean MPR values were reported on which did not allow them to be compared with the other studies.
Patient related factors
Gender & age variables
Women were statistically more likely to adhere to AEDs but only by relatively low percentages margins in four of the included studies; 10% [21] , 11% [22] , 4% [23] 8% [26] . With regards to age variables and adherence, the mean and standard deviation/ interquartile ranges for each of the studies are outlined in Table 3 .
Although no significant statistical associations were made between age and adherence rates within each of the individual four studies [21] [22] [23] 26] , when the total mean ages were compared, AED adherence appears to be more likely to occur as one gets older. In one study [21] a one-year increment in age was associated with a 3% reduction in AED non-adherence probability.
Beliefs about medications
Two studies [19, 26] examined the impact of medication beliefs using the beliefs about medicines questionnaire. Chapman et al. [19] used an epilepsy-specific belief about medicines questionnaire along with the necessity-concerns differential [29] and the perceived sensitivity to medicines scale [30] . Analysis of the specific belief scales in Chapman et al. study [19] indicated that non-adherent participants had stronger beliefs in their personal need for AEDs and more concerns about adverse effects (p < 0.05). The necessity-concerns differential was significantly lower in MPR [32] non-adherent participants indicating beliefs in need for medication were closely matched to concerns (p < 0.001). Logistic regression analysis indicated that the odds of non-adherence were significantly increased when patients' concerns about AEDs increased which demonstrated that non-adherence may in part be due to of negative beliefs about AEDs. In this study [19] , younger patients had greater medication concerns (p < 0.001) while participants with educational qualifications had lower AEDnecessity scores. These findings were not replicated in Shallcross et al. [25] where Pearson correlation coefficient rates for Beliefs about Medicines-necessity and Beliefs about Medicines-concerns scores were 0.062 and À0.058 meaning no correlations existed between beliefs about medicines and AED adherence. However, in Chapman et al. [19] the external validity was viewed as stronger due to a robust sample and the use of the Beliefs about Medicines epilepsyspecific tool.
Depression & anxiety
Two studies [20, 25] used the Neurological Disorders Depression Inventory for Epilepsy to assess depression in AWE [37] . Additionally, Ettinger et al. [20] used the Centre for Epidemiologic Studies Depression Scale [38] . Guo et al. [22] used the Beck Depression Inventory [39] to assess depression using cut-off scores for an epilepsy cohort [40] . This study also explored the impact of anxiety using the Beck Anxiety Inventory [41] .
Ettinger et al. [20] correlated depression measured by the Neurological Disorders Depression Inventory for Epilepsy with an elevated risk of non-adherence. Adherence rates were reported in mean values with a threshold of less than 80 used to define nonadherence on the MPR. The mean adherence for the non-depressed sample was 84.23 SD 17.48 and the mean adherence rate for the depressed sample was 77.00 SD 20.04 with a p-value of <0.001. This study [20] compared adherence rates between those classified as being depressed on both the Neurological Disorders Depression Inventory for Epilepsy and the Centre for Epidemiologic Studies Depression Scale and those who were not depressed. Within the non-depressed cohort (81% of the sample) the mean MPR rates was 84.0 (SD 17.6), compared to the depressed sample (19% of the sample) who had a mean MPR rate of 76.5 (SD 20.6) with a p value of 0.001.
In Guo et al. [22] , a significant difference in depression scores was reported between the low adherence group and the moderate to high adherence group (x 2 = 13.625, p < 0.001). In this study, [22] 19.6% of participants scored moderate to severe depressive symptoms with 66.7% of this group scoring scores of less than 6 on the MMAS-8 indicating low adherence rates. This was a significant rate of non-adherence compared to the non-depressed group where 33.1% were in the low adherence category. Pearson's correlations indicated that the depression scores (r = À 0.281, p < 0.001) and the anxiety scores (r = À 0.255, p < 0.001) both were negatively correlated with adherence. There was also a significant difference in anxiety scores between adherent and non-adherent participants (x 2 = 8.331, p = 0.004). On the Beck Anxiety Inventory scores 25.5% of participants, were considered to have moderate tosevere anxiety. Within this cohort, 57.4% had MMAS-8 scores less than 6, indicating low adherence. This was significant compared to the group who were deemed to have no or mild anxiety where low adherence rates of 33.6% were reported. This study [22] also reported significant differences between the groups with depressed symptoms and those with anxiety symptoms on their MMAS-8 scoring. Negative correlations were found between Beck Depression Inventory scores and items 2, 7, and 8 on the MMAS-8 (p < 0.05). Significant negative correlations were also found between with Beck Anxiety Inventory scores and item 3 and items 6 through 8 (p < 0.05). On the answers to MMAS-8, items 3 and 6-8 were negatively correlated with Beck Anxiety Inventory scores, which indicated that patients with anxiety had not only lower confidence (item 7) but also more difficulty remembering to take AEDs (item 8) and following the prescriptions of doctors (items 3 and 6). Shallcross et al. [25] measured adherence using the MMAS-8 with higher scores (maximum 8) indicting adherence. A significant correlation was reported between being depressed and non-adherence with a score of À0.379 on Pearson correlation coefficient and rates of probability values being <0.05.
Medication management
Two studies [21, 23] asked participants to report what they attributed AED non-adherence from a medication management perspective. In one study [21] , patients attributed non-adherence to forgetting doses (47.5%) and lack of time to take AEDs (39.2%).
In Hovinga et al. [23] , 72% of the participant sample and 70% of the physician sample identified forgetfulness and not having medication as a reason for non-adherence. Furthermore, adherent participants compared to non-adherent participants reported being confident in knowing how to take their medication as prescribed (93% versus 83%, p < 0.05). Adherent participants were more likely to report fitting medication taking into daily routine (53% versus 37%, p value < 0.05).
Smithson et al. [26] investigated this variable using the ESMS tool [24] . Lower medication-management scores were observed in younger people (18-30 years) (X 2 = 15.587, p = 0.001) who were employed or in full time education (X 2 = 16.44, p = 0.001) or those with high level of education who lived with others (X 2 = 14.88, p = 0.001).
Disease related factors
Ferrari et al. [21] was the only study which investigated adherence rates and epilepsy syndromes. Non-adherence rates of 69% were reported among those with symptomatic epilepsy, 53% among those with cryptogenic focal epilepsy, 58% among idiopathic generalised epilepsy and 71% among cryptogenic generalised epilepsy. These values did not allow any significant association be made between the rate of non-adherence with a specific epilepsy syndrome. Guo et al. [22] investigated if nonadherent behaviour could be linked to seizure type. However, no associations were made with similar rates of non-adherence reported among those with generalised (44%) partial (39%) and unclassified (36%) seizure classifications. Furthermore, the presence of a seizure-related lesion was not linked to low adherence as 41% of those with a lesion had low adherence compared to 59% of those with a lesion. Disease duration was not associated with more or less treatment adherence in these two studies [21, 22] .
Five studies [21] [22] [23] [24] 26] investigated for any associations between adherence and or seizure control, seizure frequency and seizure control. Ferrari et al. [21] , explored adherence with the occurrence of a seizure in the previous 30-day period according to information gathered from the participants themselves. In the group who had no seizures, 42% were adherent and 58% were in the moderate to low adherence group, which was not statistically significant. However, only 28% of those who reported a seizure in previous 30 days had high adherence compared to 72% with moderate to low adherence which was a significant finding. Guo et al. [22] study classified seizure frequency as the occurrence of <1 or !1 seizure per month. In this study [22] , no associations were made between increased seizure frequency and adherence as 56% of those with more than 1 seizure per month had moderate to high adherence compared to 44% in the low adherence group. However, in this study [22] , 65% of those who had <1 seizure per month had moderate to high adherence compared to 35% in the low adherence group who had ! one seizure per month. In Ferrari et al. [21] seizure control was categorised as controlled if there had been no seizures in previous six months and uncontrolled if seizures occurred within six-month period was correlated with adherence rates. In this study [21] , 70% of participants with uncontrolled seizure had moderate to low adherence compared to 30% who had high adherence rates. In contrast, controlled seizures were associated with a more equal distribution of non-adherence with 51% in the moderate to low category and 49% in the high adherence group.
Ferrari et al. [21] also investigated for any association between patients' perception of their seizure control on their adherence rates. Similar to the findings on seizure frequency 70% of those who viewed their epilepsy to be uncontrolled had moderate to low adherence rates. In contrast the adherence rates among those who viewed their epilepsy as controlled was more evenly distributed with 49% having high adherence and 51% having moderate to low adherence.
In Hovinga et al. [23] poorer seizure control was associated with non-adherence, with 39% in the non-adherent group having had experienced a convulsion during the previous year compared to 18% in the adherent group. In this study [23] 63% of non-adherent participants had at least 1 seizure per year compared to 36% of adherent participants. In Jones et al. [24] a strong correlation existed between poor seizure control and non-adherence with 63% of those with poorly-controlled epilepsy being non-adherent compared to 38% of the well-controlled group. In this study, [24] well controlled epilepsy was defined as the occurrence of less than one seizure poor month.
In Smithson et al. [26] only the length of time since the last seizure rather than the actual seizure frequency was related to non-adherent behaviour. In this study, 41% of the non-adherent participants reported having had a seizure in the previous 6 months compared to 31% of adherent participants with a p-value of 0.008. Shallcross et al. [25] measured the impact of illness perception on adherence using the 8-item Brief Illness Perception Questionnaire [42] . No association was made between adherence rates and illness perception rates with Pearson correlation coefficient being À0.244 and a probability value of <0.05.
Medication related factors
In Ferrari et al. [21] 45% of participants on monotherapy were deemed to have high adherence with the remaining 56% on monotherapy being viewed as having moderate to low adherence. However, only 29% of participants on polytherapy were classified as having high adherence with the remaining 71% having moderate to low adherence. It is worth noting that in this study [21] 29% of the total sample was receiving monotherapy, which therefore increases the validity of the findings regarding polytherapy and adherence rates.
This study [21] also identified that treatment complexity was associated with non-adherence, as a one-point increment in Epilepsy Medication and Treatment Index [43] was associated with a 6% increase in treatment non-adherence probability. According to Ferrari et al. [21] the EMTCI is a specifically designed tool, which assesses medication regimen complexity in AWE. This questionnaire collected information on medication use, medication administration frequency, and special directions and actions to ensure that medications are taken as prescribed [21] .
Guo et al. [22] did not associate non-adherence with mono/ polytherapy with 58% of participants on monotherapy and 62% of participants on polytherapy having moderate to high adherence based on their MMAS-8 scores. However, an association was made between dosing frequencies and adherence rates with 62% of participants who took 2 medication doses per day being considered adherent compared to 52% of participants on dosing frequencies of !3 times per day.
Healthcare related factors
Ferrari et al. [21] findings did not indicate that the quality of medical care, perception of health status after beginning treatment in outpatient clinic, medication source, or actions taken when free AEDS are unavailable impacted on adherence. Hovinga et al. [23] investigated the impact of the patient-physician relationship with 34% of adherent participants indicating they trusted their doctor compared to 17% of non-adherent participants. Furthermore, adherent participants reported being comfortable discussing missed medications with their doctor (27% versus 12%). Being an online study [23] , the findings are augmented by geographical healthcare variances.
Socio Àeconomic factors
In Ferrari et al. [21] , the perceived support of family members/ friends was not associated with adherent behaviour. In three studies [22, 23, 26] no association was made between social support and adherence. Only Shallcross et al. [25] reported perceived social support been a significant predictor of adherence on multiple linear regression tests with a p-value < 0.05. However, a major difference between Shallcross et al. [25] and other studies [22, 23, 26] was that perceived support was assessed using the 12-item Interpersonal Self Evaluation List [44] rather than categorising support systems based on either participant martial or living status.
Four studies [21] [22] [23] 26 ] examined for associations between employment status/income/education level on adherence. In Ferrari et al. [21] , adherence rates were correlated with education level and employment status. No significant statistical association was made with 68% of the low adherence group being employed and 65% being unemployed. Among those classified as being adherent, 37% were educated for less than four year, while 32% had been educated for more than four years, making no associations between education level and adherence. In Guo et al. [22] no significant associations were made between those with high school or college graduates and adherence. Similarly, among those who were classified as either a student, employed or unemployed the rates of non-adherence was similar with rates of 63%, 60% and 59% respectively. Hovinga et al. [23] made no associations between educational attainment and adherence rates with equal rates of adherence and non-adherence among those who attended either less than high school/high school/college and graduate school. This study [23] also examined for associations between adherence and income rates. While there was no significant statistical association between lower and higher incomes and adherence rates, there was a higher percentage of adherent participants in the higher incomes groups compared to non-adherent participants (11% versus 7%). In Smithson, et al. [26] , no significant differences existed between adherence and non-adherence groups in terms of educational qualifications achieved. In this study [26] , within the adherent group 47% of participants had no qualification, 27% had CSE/O Levels and 26% had a AS/A LEVEL/degree. In the non-adherent group, 32% had no qualification, 27% had CSE/O Levels and 41% had a AS/A LEVEL/degree.
Secondary outcomes
One study [23] reported on the impact of non-adherence on QoL. QoL was measured using the SF-12 Health Survey [45] , the Medical Outcomes Study-cognitive functioning [46] and the Health and Work Questionnaire [47] . Non-adherent participants scored significantly lower on SF-12-Mental Health and Medical Outcomes Study-cognitive functioning surveys in addition to been more likely to report experiencing job loss and school/occupational absenteeism due to depression. On the SF-12, Physical Heath survey, adherent and non-adherent participants had similar outcomes. On the Health and Work Questionnaire scores, adherent participants scored higher on their own productivity, concentration and the Health and Work Questionnaire total. Non-adherent participants were more likely than adherent participants to report having had to miss work/school due either a seizure, thinking/ memory abilities (38% versus 21%, p < 0.005) or feared embarrassment of having a seizure in front of classmates/co-workers (31% versus 16%, p < 0.05).
Discussion
To our knowledge, this is the first systematic review which explored the barriers to medication adherence among AWE. A high prevalence of AED non-adherence was identified across the eight included studies [19] [20] [21] [22] [23] [24] [25] [26] with rates from 29 to 66% reported, which highlighted the magnitude of this problem. The definition of adherence varied across the studies depending on the assessment tool used. Additionally, between two studies [21, 24] which used the same adherence measurement tool, differences in the scoring and determination of non-adherence was evident. Five studies used self-report methods to assess adherence [21] [22] [23] [24] [25] . The MMAS tool was used in four studies [21, 22, 24, 25] where questions are phrased to avoid "yes-saying" and each item measuring a specific medication taking behaviour [36] . Research has compared it favourably with electronic medication monitoring devices [48] . The one-month recall period used Hovinga et al. [23] to assess adherence is associated with less over reporting of adherence in assessing medication adherence in other chronic illness [49] .
Two studies [19, 26] used a mixed methods approach using two items from the ESMS related to medication taking along with use of MPR. The two studies [19, 26] acknowledged that although the ESMS has not been validated to measure adherence, they refer to its use in previous research [18] . Ettinger et al. [20] was the only study that did not use a self-report tool, instead using the MPR tool [32] . MPR measures the time a patient has access to medications in percentage rates [50] and uses the 80% threshold to define adherence. It's argued that this percentage may not be relevant for epilepsy despite having validity in other chronic illnesses [50] . Additionally, access to medication does not necessarily equate with the actual act of medication taking.
It is widely recognised that there are no gold standard methods for measuring medication adherence [51, 52] . The use of self-report questionnaires increases the risk of blinding bias, either due to fallible memory or efforts to appear responsible [50] . Finally, different views exist on the necessary time period required to gauge adherence. It is suggested that among patients with chronic illnesses, a 3-4-day recall period of adherence estimates is practically as reliable and valid as longer intervals [53] . However, others argue, adherence assessments should be carried out over periods more than or equal to 90 days to allow for variances in behaviour among people with epilepsy [50] .
This SR demonstrated that the barriers to AED adherence are multifactorial and reflected the complexities and influences on patients' decision making about whether or not to take their medication as prescribed. From the findings, patient related factors most strongly influenced AED adherence. In one study [19] nonadherence was significantly associated with perceptual barriers, therefore adherence support interventions with AWE must address patients' beliefs about their AEDs to elicit any unfounded fears or concerns [54] . Depression [20, 22, 25] and anxiety [22] was associated with non-adherence. Depressed mood has been identified as leading to reduced motivation to take medications properly [55] . Significantly one-third of AWE suffers from depression and anxiety which is often under recognized [56] . The use of simple screening methods to detect symptoms of depression/anxiety has been advocated within epilepsy care [56] . This may also assist with improving adherence by identifying high risk groups.
In four studies [21] [22] [23] 26] adherence was more likely to occur as one gets older which is similar to a well-known earlier piece of research by Buck et al. [16] . Age related factors are possibly related to medication beliefs, as it is recognised that patients' realisation of the benefits of their medication may occur through time [15] . Age related factors would also appear to link in with medication management skills. As younger educated AWE were identified to have poorer self-management skills in one study [26] , discussions on the individual meaning of medication taking should take place as taking medication can be viewed as stigmatising and a reminder of one's condition [3] .
From the findings [21, 23, 26] , it was evident that behavioural change is required for AWE to incorporate medication taking into their lives to improve adherence. The use of postal reminders for prescription refills has been shown to increase adherence rates in addition to the use of pill boxes and blister packing [57] . Above all, prescribers should be aware of the "health literacy" of their patients by assessing their ability to process and understand instructions in order to make appropriate decisions [52] . Using simple, explicit language when giving instructions to patients about their medicines has been noted to improve adherence [52] .
While, only one study [21] associated monotherapy with higher adherence rates, research would suggest monotherapy improves adherence by offering better tolerability and avoidance of drug interactions [58, 59] . Increased AED dosing frequencies were associated with lower adherence rates within the two included studies that investigated this variable. [21, 22] . It is known that patients with chronic diseases are more likely to adhere with oncedaily than more frequently scheduled medication regimens [60] .
In this review, the highest rates of non-adherence were reported among those with cryptogenic generalised epilepsy [21] and partial seizures [22] . Four studies demonstrated a strong relationship between worsened seizure control and AED nonadherence [21] [22] [23] [24] . The occurrence of seizures within the previous 30 days was significantly associated with non-adherence in one study [21] and within the previous six months in another study [26] . An interesting finding was that 70% of AWE in Ferrari et al. [21] who viewed their epilepsy as uncontrolled were found to have only moderate to low rates of adherence. While there will always be a relationship between poor seizure control and non-adherence due to inadequate AED levels, further exploration of the relationship between seizure control and illness perception may improve our understanding as to why worsened seizure control may lead to non-adherence.
The patient-prescriber consultation has been viewed as having a strong influence on patients' medication taking behaviour [61] . Our findings were similar in so far as the patient-physician relationship was the only identified healthcare variable to impact on adherence [23] . This reiterates the importance of providing an environment where patients can be open and honest about how they manage their epilepsy and comfortable in raising concerns about taking medicines [18] . In recent times, the need for greater patient involvement in clinical decision-making is been recognised and applicable to situations such as choice of medication, with positive health outcomes such as increased concordance [62] . One study [25] identified perceived social support been a significant predictor of adherence. This would appear to indicate the significant role family and friends play in encouraging adherence.
Finally, secondary outcome measures highlighted that epilepsy as a chronic disease relies heavily on medication in order to maximise QoL for AWE [3] . Unlike other conditions, the effects of non-adherence can be more immediate with poor seizure control [3] . From the findings, its clear that improving adherence rates is not just about improving seizure control but ultimately, optimising the QoL of people with a long-term illness.
The use of cross-sectional study designs within all the studies inhibited determining causality, therefore prospective longitudinal designs are recommended for future research. Another limitation of this review was the decision to define an adult as being 18 years or older, which was guided by current Irish legislation and research guidelines [63] which differs from other jurisdictions [64] . A follow-up SR would benefit from broadening the age limits to include 16-18 year olds as robust studies were excluded for including participants aged 16 upwards.
Conclusion
While large heterogeneity between the included studies hampered making systematic conclusions, six of the included studies were identified to be statistically sound which added credence to the overall findings. Although identified biases compromised findings, variances among the study populations and settings increased generalisability.
This SR highlighted how vital the relationship is between the prescriber and the patient with the reasons for AED non-adherence being multifactorial. Comprehensive adherence assessments should be a routine part of clinical encounters, with the aim of identifying potentially modifiable factors.
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